Recombinant Conopeptide

• 

  Recombinant Conopeptides

  This is not a trivialing problem since millions of people throughout the world are affected by chronic pain and it severely affects their quality of life. It can affect their work, hobbies, and social activities with family and friends. These animal addictives are common pain medicines such as opioid and may produce harmful side effects that negatively affect the matter. Science has given us the tools to provide people safer, more effective pain relief without the risks associated with our current arsenal of analgesics through the technology of recombinant conopeptides.

• 

  Recombinant Conopeptide Therapy

  We can apply what we learn from the unique compounds in cone snail venom to produce effective pain relief medicines. These Recombinant Human Serum Albumin (HSA) can be created targeted to different forms of pain and work by making people feel better psychopharmacologically without having to take them always. Such, that patients will have a better quality of life and perform their common activities more leisurely because they will not be tied to pain or hour medications.

• 

  Treating Chronic Pain with Recombinant Conopeptide Technology

  But here at Yaohai, we keep looking for more and better solutions to fight chronic pain. We believe we can change the way that we treat pain, using Рекомбинантен ИГФ-1 Производство technology to deliver safer and more effective treatment options. The researchers on our team cannot wait to see how this influences the lives of millions of people who experience chronic pain. We feel that this type of focus on the most sophisticated treatments is our way to have a real impact for many people.

Why choose Yaohai Recombinant Conopeptide?

• Систем за квалитет и глобална регулаторна усогласеност

  Recombinant Conopeptide is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have established a robust quality system that complies with the current GMP standards and regulations all over the world. Our regulatory team is well-versed on global regulatory frameworks to speed up biological launches. We guarantee traceable production processes and top-quality products that are compliant with the rules of US FDA, EU EMA, Australia TGA, and China NMPA. Yaohai BioPharma successfully passed an audit on site conducted by an accredited Qualified Person from the European Union (QP) to review our GMP system and production facility. Additionally, we've passed the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

• Силен синџир на снабдување и производствени способности

  Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have created a Recombinant Conopeptide manufacturing facility with robust RD capabilities and cutting-edge manufacturing facilities. Five drug substance production lines conforming to GMP standards to purify and ferment microbial cells, as well as two fill and finish lines for vials and cartridges, as well as needles that are pre-filled, are available. The available fermentation scales include 100L, 500L, 1000L and 2000L. Specifications for filling vials range from 1ml - 25ml. the pre-filled cartridge or syringe filling specifications range from between 1-3ml. The production workshop is cGMP-compliant and provides a stable supply of commercial products and clinical samples. Our facility produces large molecules that are shipped worldwide.

• Прилагодување, ефикасност и економичност

  Recombinant Conopeptide has experience in manufacturing biologics that are that are derived from microorganisms. We provide tailored RD as well as manufacturing solutions, while minimising the risk. We have experimented with a variety of techniques, such as recombinant cellular subunits of vaccines (including peptides), growth factors, hormones and the cytokines. We have specialized in multiple microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) and bacteria intracellular soluble and inclusion bodies (yields up to 10g/L). We also have the BSL-2 fermentation platform to develop bacterial vaccines. We are experts in improving processes, increasing product yields, and decreasing production costs. With an effective technology team, we ensure timely and quality project delivery and bring your products to market faster.

• Професионална експертиза и долгогодишно искуство

  Recombinant Conopeptide is a leading in microbial biologics CDMO. Our focus has been on microbial-produced vaccines and therapeutics that are suited for human, veterinary, as well as pet health management. We have the most cutting-edge RD platforms and manufacturing technology which cover the entire procedure beginning with the development of microbial strains and cell banking, to process and method development, to commercial and clinical production which ensures successful delivery of innovative solutions. Over time, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed, and we assist our clients to comply with regulations like those of US FDA and EU EMA. We also help them to navigate Australia TGA and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide bespoke CDMO services.

Поврзани категории на производи

• Рекомбинантен аналог на инсулин биопроизводство
• Производство на рекомбинантен инсулин
• Биопроизводство на рекомбинантна мутација на инсулин
• Рекомбинантен свински инсулин биопроизводство
• GMP рекомбинантни пептиди Производство
• Recombinant Annexin 5 Manufacturing
• Recombinant Antigen GMP Manufacturing
• Рекомбинантен говедски серумски албум (BSA)
• Рекомбинантен серумски албум за кучиња (CSA)
• Recombinant Clusterin (CLU) Manufacturing
• Recombinant Conopeptide

Не го наоѓате тоа што го барате?
Контактирајте ги нашите консултанти за повеќе достапни производи.